7BKO

Crystal structure of CHK1 complex with compound 9

7BKO の概要

• エントリーDOI: 10.2210/pdb7bko/pdb
• 関連するPDBエントリー: 7bjd 7bje 7bjh 7bjj 7bjm 7bjo 7bjr 7bjx 7bk1 7bk2 7bk3
• 分子名称: Serine/threonine-protein kinase Chk1, 1H-pyrazolo[3,4-d]pyrimidin-4-amine (3 entities in total)
• 機能のキーワード: parkinson's disease, leucine-rich repeat kinase 2, lrrk2, checkpoint kinase 1, chk1, mutant, surrogate, kinase inhibitor, sbdd, transferase
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 34283.28

構造登録者

Baker, L.M.,Surgenor, A.E.,Williamson, D.S. (登録日: 2021-01-16, 公開日: 2021-07-07, 最終更新日: 2024-01-31)

• 主引用文献: Williamson, D.S.,Smith, G.P.,Mikkelsen, G.K.,Jensen, T.,Acheson-Dossang, P.,Badolo, L.,Bedford, S.T.,Chell, V.,Chen, I.J.,Dokurno, P.,Hentzer, M.,Newland, S.,Ray, S.C.,Shaw, T.,Surgenor, A.E.,Terry, L.,Wang, Y.,Christensen, K.V.; Design and Synthesis of Pyrrolo[2,3- d ]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate.; J.Med.Chem., 64:10312-10332, 2021; PubMed: 34184879; DOI: 10.1021/acs.jmedchem.1c00720

実験手法

X-RAY DIFFRACTION (2.3 Å)